Hanneke joined NLC in September 2022. Her background is in neuroimmunology, having undertaken a PhD in mast-cell nerve interaction in asthma at Utrecht University in the Netherlands followed by a postdoctorate at the Brain-Body Institute in Hamilton, Canada. Before joining NLC, Hanneke worked as a Senior Scientist and Clinical Trial Manager at HAL Allergy, a pharmaceutical company developing immunotherapy for patients with different types of allergy. Hanneke is eager to use her experience in the different NLC projects related to (neuro)immunology and extend her expertise also towards other scientific areas as well as to get familiar with the processes involved in venture building, bringing healthtech innovations from bench to bedside.